Fidelity Investments’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-78,796
| Closed | -$1.77M | – | 5672 |
|
|
2023
Q2 | $1.77M | Sell |
78,796
-2,327
| -3% | -$52.4K | ﹤0.01% | 2349 |
|
|
2023
Q1 | $981K | Sell |
81,123
-455
| -0.6% | -$5.5K | ﹤0.01% | 2531 |
|
|
2022
Q4 | $371K | Sell |
81,578
-214
| -0.3% | -$974 | ﹤0.01% | 2816 |
|
|
2022
Q3 | $537K | Sell |
81,792
-254
| -0.3% | -$1.67K | ﹤0.01% | 2761 |
|
|
2022
Q2 | $885K | Sell |
82,046
-56
| -0.1% | -$604 | ﹤0.01% | 2707 |
|
|
2022
Q1 | $1.57M | Sell |
82,102
-106
| -0.1% | -$2.02K | ﹤0.01% | 2675 |
|
|
2021
Q4 | $2.95M | Buy |
82,208
+10,536
| +15% | +$378K | ﹤0.01% | 2481 |
|
|
2021
Q3 | $5.26M | Buy |
71,672
+12,210
| +21% | +$897K | ﹤0.01% | 2352 |
|
|
2021
Q2 | $8.29M | Sell |
59,462
-2,938
| -5% | -$410K | ﹤0.01% | 2180 |
|
|
2021
Q1 | $18.1M | Sell |
62,400
-11,015
| -15% | -$3.2M | ﹤0.01% | 1838 |
|
|
2020
Q4 | $45.8M | Buy |
+73,415
| New | +$45.8M | ﹤0.01% | 1352 |
|